SlideShare a Scribd company logo
1 of 129
Download to read offline
Immunology & Immunological Preparations 
1 
By: Bijaya Kumar Uprety
Immunology 
•Branch of biological science concerned with the study of immunity, 
•Or concerned with the structure and function of immune system. 
Immunity 
•Latin term immunismeaning “exempt”. 
•Immunity means the state of protection from infectious disease. 
2
 
 
 
 
 
 
Year 
Name 
Event 
430 B.C –Earliest written reference to the phenomenon of immunity. 
Thucydides (great historian of the Peloponnesian war). 
In describing plague in Athens, he wrote during the war, only who had recovered from the plague could nurse the sick because they would not get the disease for the second time. 
15thcentury-First record to induce immunity deliberately. 
Chinese and Turks 
Dried crust derived from small pox pustules were either inhaled into the nostrils or inserted into small cuts in the skin (technique known as variolation). 
1718 
Lady Mary Wortley (wife of british ambassador to Constantinople) 
Performed variolationon her own children after realizing the technique was effective among her native people. 
1798 
Edward Jenner (physician) 
Propounded an idea that introducing fluid from a cowpox pustule into people might protect them from smallpox and he tested his idea on eight year old kid which was successful. 
3
Louis Pasteur grew the fowl cholera causing bacterium in culture and when this was injected it into chicken they developed cholera but later on when he once again injected them with the same old culture they got ill but recovered later on. 
He grew fresh culture and tried it on same chickens. They completely recovered. 
Hence, Hypothesized and proved that aging had weakened the virulence of the pathogen and concluded that the attenuated strain might be administered to protect against the disease. He called this attenuated strain a vaccine. 
4
Continue….. 
Laterextendedhisfindingstootherdiseasesanddemonstrateditispossibletoattenuate,orweakenapathogenandadministerthemtouseitasavaccine. 
In1881,Pasteurvaccinatedonegroupofsheepwithheat-attenuatedanthraxbacillus(bacillusanthracis) andleftanothergroupofunvaccinatedsheep.Allunvaccinatedsheepdiedwhileotherlived. 
Thiswasthebeginningsofthedisciplineofimmunology.In1885,hefirstadministeredhisfirstvaccinetoahuman(ayoungboy)againstrabies. 
5
Pasteur proved vaccination worked but didn’t know how it worked. 
In 1890, Emil von Behring and Shibasaburo Kitasato gave first insight into the mechanism of immunity Got nobel prize in 1901. 
They demonstrated that serum from animals previously immunized to diptheria could transfer the immune state to unimmunized animals. 
6
Duringnextdecade,itwasdemonstratedbyvariousresearchersthatanactivecomponentfromimmuneserumcouldneutralizetoxins,precipitatetoxinsandagglutinatebacteriaandactiveagentwasnamedforitsactivityitexhibited:antitoxin,precipitinandagglutininresp. 
Initiallydifferentserumcomponentwasthoughttoberesponsibleforeachactivitybutduring1930,ElvinKabat(mainlyhim)foundthatgamma-globulin(nowimmunoglobulin,alsoafractionofserum)wasresponsibleforallthese. 
7
The active molecules in the immunoglobulin fraction are called antibodies. 
Because the immunity was mediated by antibodies contained in the fluids (known at that time as humors), it was called humoral immunity. 
In 1883, Elie Metchnikoff demonstrated that cells also contribute to the immune state of an animal. He hypothesized that cells rather than serum components were major effector of immunity.(term phagocytes was coined and an idea of cell-mediated immunity dvpt). 
Controversy developed between two concepts. 
8
But latter proved that both were correct. 
Immunity requires both humoraland cellular responses. 
In 1950, lymphocyte was identified as the cell responsible for both cellular and humoralimmunity and experiments on chicken pioneered by Bruce Click at Mississippi State University indicated that there are two types of lymphocytes. 
1.T-lymphocytes derived from thymus mediated cellular immunity. 
2.B-lymphocytes from bursa of Fabriciuswere involved in humoralimmunity. 
Both these systems work hand in hand to protect our body against various foreign attack. 
9
Introduction to Immune system 
Remarkably versatile defense system that protect animals against various invading micro-organisms and cancer. 
Able to generate enormous variety of cells and molecules capable of specifically recognizing and eliminating large variety of foreign invaders. 
Invaders human bodyimmune system respondeliminate or destroys the invaders 
10
Bodyendowedwithdifferentdefensesystem. 
Atfirst,externaldefensesystemcomesintoplaywhichincludes,skin,secretionofmucus,ciliaryaction, lavagingactionofbactericidalfluids(e.g.tears), gastricacidandmicrobialantagonism. 
Ifpenetrationoccurs,bacteriaaredestroyedbysolublefactorssuchaslysozymeandbyphagocytosiswithintracellulardigestion. 
11
Functionally, immune response can be divided into two related activities- 
1.Recognition –Remarkable for its specificity. 
2.Response. 
Immune system is able to recognize subtle chemical differences that recognize one foreign pathogen from another. 
Able to discriminate between foreign molecules and the body’s own cells and proteins. 
12
Once a foreign organism has been recognized, it recruits a variety of cells and molecules to mount an appropriate response, called effectorresponse, to eliminate or neutralize the organism. 
The immune response enables the elimination or neutralization of the cells/molecules (pathogens) from the body. 
Convert initial recognition event variety of effectorresponseseliminate or neutralize particular pathogen. 
13
Later exposure to the same foreign organism induces a memory response, characterized by a more rapid and heightened immune reaction that serves to eliminate the pathogen and prevent disease. 
14
Types of immunity 
Two types of immunity: 
1. Innate or nonspecific immunity. 
2. Acquired or specific immunity. 
Innate immunity: 
It is the basic resistance to diseases that an individual has from the time of its birth. 
Not specific to any one pathogen but rather constitutes a first line of defense. 
15
It consists of following four types of defensive barriers: 
1.Anatomic barriers 
2.Physiologic barriers 
3.Endocytosis/phagocytosisbarriers 
4.Inflammatory barriers 
16
17
•Endocytosis-Processofcellularingestionofmacromoleculesbyinvaginationofplasmamembranetoproduceanintracellularvesiclewhichenclosestheingestedmaterial. 
•3types- 
Phagocytosis(forparticulates), 
Pinocytosis(liquid), 
Receptormediatedendocytosis(LDL). 
•Mostphagocytosis(mostcommon)isdonebybloodmonocytes,neutrophils, andtissuemacrophages. 
Fig. Steps in phagocytosis of a bacterium. 
18
Fig 2 showing the major events in the inflammatory response.[ vasoactive and chemotactic factors i.e kinin and histamine. Additionally , bradykinins which is a type of kinin stimulate pain receptors and fibrin-clot] 19
Acquired Immunity 
Also known as adaptive immunity. 
Capable of recognizing and selectively eliminating specific foreign microorganisms and molecules (i.e. foreign antigens). 
Displays four characteristic attributes: 
1.Antigenic specificity 
2.Diversity 
3.Immunologic memory 
4.Self/nonselfrecognition. 
20
Components of Acquired Immunity 
Involves the following two major groups of cells 
1.Lymphocytes which includes B and T lymphocytes. 
2. Antigen presenting cells (APCs)- 
Group of B-cells, dendriticcells and macrophages. 
They express class II MHC molecules on their membranes & 
They are able to deliver a co-stimulatory signal that is necessary for THcell activation. 
APC have Class II MHC (major –histocompatibilitycomplex) molecules on their surfaceMHC molecules bind to antigen derived peptidespresent them to lymphocytes immune system activated. 
21
B lymphocytes 
Blymphocytesmaturewithinthebonemarrow;whentheyleaveit,eachexpressesauniqueantigen-bindingreceptoronitsmembrane.Thisantigen-bindingorB-cellreceptorisamembrane-boundantibodymolecule. 
Antibodiesareglycoproteinsthatconsistoftwoidenticalheavypolypeptidechainsandtwoidenticallightpolypeptidechains.Eachheavychainisjoinedwithalightchainbydisulfidebonds,andadditionaldisulfidebondsholdthetwopairstogether. 
Theamino-terminalendsofthepairsofheavyandlightchainsformacleftwithinwhichantigenbinds. 
WhenanaiveBcell(onethathasnotpreviouslyencounteredantigen)firstencounterstheantigenthatmatchesitsmembraneboundantibody,thebindingoftheantigentotheantibodycausesthecelltodividerapidly;itsprogenydifferentiateintomemoryBcellsandeffectorBcellscalledplasmacells. 
MemoryBcellshavealongerlifespanthannaivecells,andtheyexpressthesamemembrane-boundantibodyastheirparentBcell. 
Althoughplasmacellsliveforonlyafewdays,theysecreteenormousamountsofantibodyduringthistime.Ithasbeenestimatedthatasingleplasmacellcansecretemorethan2000moleculesofantibodypersecond.Secretedantibodiesarethemajoreffectormoleculesofhumoralimmunity. 
22
23
24
T lymphocytes 
Tlymphocytesalsoariseinthebonemarrow.UnlikeBcells,whichmaturewithinthebonemarrow,Tcellsmigratetothethymusglandtomature. 
Duringitsmaturationwithinthethymus,theTcellcomestoexpressauniqueantigen-bindingmolecule,calledtheT-cellreceptor,onitsmembrane. 
Unlikemembrane-boundantibodiesonBcells,whichcanrecognizeantigenalone,T-cellreceptorscanrecognizeonlyantigenthatisboundtocell- membraneproteinscalledmajorhistocompatibilitycomplex(MHC) molecules. 
MHCmoleculesthatfunctioninthisrecognitionevent,whichistermed“antigenpresentation,”arepolymorphic(geneticallydiverse)glycoproteinsfoundoncellmembranes. 
TherearetwomajortypesofMHCmolecules: 
ClassIMHCmolecules,whichareexpressedbynearlyallnucleatedcellsofvertebratespecies,consistofaheavychainlinkedtoasmallinvariantproteincalled2-microglobulin. 
ClassIIMHCmolecules,whichconsistofanalphaandabetaglycoproteinchain,areexpressedonlybyantigen-presentingcells. 
25
WhenanaiveTcellencountersantigencombinedwithaMHCmoleculeonacell, theTcellproliferatesanddifferentiatesintomemoryTcellsandvariouseffectorTcells. 
Therearetwowell-definedsubpopulationsofTcells:Thelper(TH)andTcytotoxic(TC)cells.AlthoughathirdtypeofTcell,calledaTsuppressor(TS)cell, hasbeenpostulated,recentevidencesuggeststhatitmaynotbedistinctfromTHandTCsubpopulations. 
ThelperandTcytotoxiccellscanbedistinguishedfromoneanotherbythepresenceofeitherCD4orCD8membraneglycoproteinsontheirsurfaces.TcellsdisplayingCD4generallyfunctionasTHcells,whereasthosedisplayingCD8generallyfunctionasTCcells.THcellsgenerallyrecognizeantigencombinedwithclassIImolecules,whereasTCcellsgenerallyrecognizeantigencombinedwithclassImolecules. 
AfteraTHcellrecognizesandinteractswithanantigen–MHCclassIImoleculecomplex,thecellisactivated—itbecomesaneffectorcellthatsecretesvariousgrowthfactorsknowncollectivelyascytokines.ThesecretedcytokinesplayanimportantroleinactivatingBcells,TCcells,macrophages,andvariousothercellsthatparticipateintheimmuneresponse. 
26
DifferencesinthepatternofcytokinesproducedbyactivatedTHcellsresultindifferenttypesofimmuneresponse. 
UndertheinfluenceofTH-derivedcytokines,aTCcellthatrecognizesanantigen–MHCclassImoleculecomplexproliferatesanddifferentiatesintoaneffectorcellcalledacytotoxicTlymphocyte(CTL). 
IncontrasttotheTHcell,theCTLgenerallydoesnotsecretemanycytokinesandinsteadexhibitscell-killingorcytotoxicactivity. 
TheCTLhasavitalfunctioninmonitoringthecellsofthebodyandeliminatinganythatdisplayantigen,suchasvirus- infectedcells,tumorcells,andcellsofaforeigntissuegraft. CellsthatdisplayforeignantigencomplexedwithaclassIMHCmoleculearecalledalteredself-cells;thesearetargetsofCTLs. 
27
ANTIGEN-PRESENTING CELLS 
Activationofboththehumoralandcell-mediatedbranchesoftheimmunesystemrequirescytokinesproducedbyTHcells. 
ItisessentialthatactivationofTHcellsthemselvesbecarefullyregulated,becauseaninappropriateT-cellresponsetoself- componentscanhavefatalautoimmuneconsequences. 
ToensurecarefullyregulatedactivationofTHcells,theycanrecognizeonlyantigenthatisdisplayedtogetherwithclassMHCIImoleculesonthesurfaceofantigen-presentingcells(APCs). 
Thesespecializedcells,whichincludemacrophages,Blymphocytes, anddendriticcells,aredistinguishedbytwoproperties:(1)theyexpressclassIIMHCmoleculesontheirmembranes,and(2)theyareabletodeliveraco-stimulatorysignalthatisnecessaryforTH-cellactivation. 
Antigen-presentingcellsfirstinternalizeantigen,eitherbyphagocytosisorbyendocytosis,andthendisplayapartofthatantigenontheirmembraneboundtoaclassIIMHCmolecule.TheTHcellrecognizesandinteractswiththeantigen–classIIMHCmoleculecomplexonthemembraneoftheantigen-presentingcell.Anadditionalcostimulatorysignalisthenproducedbytheantigen- presentingcell,leadingtoactivationoftheTHcell. 
28
29
30
HumoralImmune Responses 
It is based on antibodies. 
It can be conferred on nonimmune individuals by administration of serum antibodies from an immune individual. 
Antibodies act as an effector of humoral response. 
They bind to the antigens and facilitate their elimination. 
Elimination could be in various ways. 
31
Fig showing the structure of Antibody. 
32
1. By forming clusters through cross-linking of antigen molecules, which are readily ingested by phagocytic cells. 
2. By binding of antibodies to a microorganism can activate the complement system, which lyses the mo’s. 
3. Antibodies bind to toxins and viral particles, and prevent their subsequent binding to host cells. 
33
Cell-mediated Immune Responses 
Based on T cells, which are a type of lymphocyte. 
T cells are of the following two types: 
1.T helper (TH) 
2.T cytotoxic(TC) cells. 
TH cell interacts with an antigen –MHC II molecule complex present on an APC cytokines secreted cytokines activate B cells, TcCells, and various phagocyticcells. 
34
Activatedphagocyticcellsabletokillmo’s(bacteriaandprotozoa). 
WhenTccellinteractswithanantigen-MHCIcomplex,theTccellproliferatesundertheinfluenceofcytokinesproducedbyactivatedTHcells. 
TheseTccellsdifferentiateintocytotoxicTlymphocytes(CTLs).TheCTLskillallsuchcellsthatdisplayforeignantigenscomplexedwithMHCImolecules.Suchcellsarecalledalteredself-cells,theyareusuallyvirus-infectedcells,tumorcellsandforeigntissuecells. 
35
Thus TH cells and CTLs are effectors of the cell- mediated immune response. 
36
Fig 2. Overview of humoral and cell mediated immune responses. 
37
Passive Immunization 
Itistheadministrationofpreformedantibodies(usuallyIgG)eitherintravenouslyorintramuscularly. 
UsedtoproviderapidprotectionincertaininfectionssuchasdiptheriaortetanusorintheeventofaccidentalexposuretocertainpathogenssuchashepatitisB. 
Alsousedtoprovideprotectioninimmunecompromisedindividualswhoareunabletoproduceappropriateantibodyresponseorinsomeinstancesincapableofmakinganyantibodyatall(i.e.severecombinedimmunodeficiency). 
38
Antibodies given to immune deficient patients are usually IgG-derived from pooled normal plasma and are administered on a continuous basis (ideally every three weeks) as they are continuously catabolized and are effective only for short duration. 
Preformed antibodies from animals, notably horse are also administered for some diseases but it presents a danger of immune complex formation and serum sickness (if repetitively injected). 
39
Active immunization 
Administration of vaccines containing microbial products with or without adjuvantsin order to obtain long term immunological protection against the offending microbe. 
2 types: 
1.Systemic Immunization. 
2. Mucosal Immunization. 
40
Systemic Immunization 
This is the method of choice at present for most vaccinations. 
Carried out by injecting vaccine subcutaneously or intramuscularly into the deltoid muscle. 
Ideally all vaccines given soon after birth but some deliberately delayed. 
Common egincludes vaccines for measles, mumps, and rubella usually given at the age of 1. If given earlier maternal antibody would decrease their effectiveness. 
41
ButcarbohydratevaccinesforPneumococcus, Meningococcus,andHaemophilusinfectionsaregivenatabout2yearsasbeforethisagetheyrespondpoorlytopolysaccharidesunlesstheyareassociatedwithproteincomponentsthatcanacttorecruitTcellhelpfordevelopmentofanti-polysaccharideantibody. 
42
Mucosal Immunization 
Mostoftheinfectiousagentsgainentrytothesystemicsystemthroughmucosalrouteandthelargestsourceoflymphoidtissueisalsopresentatthemucosalsurfaces. 
Thusrecentvaccinationapproacheshavefocussedonthemucosalrouteasthesiteofchoiceforimmunizationeitherorallyorthroughthenasalassociatedimmunetissue(NALT). 
Moreover,iteliminatetheneedforpainfulinjectionandallowforself-administrationofcertainvaccinessuchasthoseforimmunizationagainstinfluenza. 
43
Adjuvant vaccines and live vector vaccines have been used to target mucosal immune system with some success. 
Attenuated strains of salmonella can act as a powerful immune stimulus as well as acting as carriers of foreign antigens. 
This approach has been used to immunize against mucosal surfaces against herpes simplex virus and human papillomavirus. 
Bacterial toxins, egthose derived from cholera, E. coli etc which posses immunomodulatoryproperties are also being exploited in the dvptof mucosallyactive adjuvants. 
44
Table 1. Passive immunization 
45
Vaccine 
Vaccineisapreparationcontainingapathogen(diseaseproducingorganism)eitherinattenuatedorinactivatedstate. 
Thispreparationisintroducedintoanindividualtoinduceadequateantibodyproductionagainstthepathogeninquestionsothattheindividualbecomesprotectedagainstinfection,atalaterdate,bythatpathogen. 
Theintroductionofavaccineinanindividualiscalledvaccinationorimmunizationasitleadstothedevelopmentofimmunityinthevaccinatedindividualstotheconcernedpathogen. 
46
The immunity is induced by the antigens of pathogen origin present in the vaccine. 
Conventionally, various vaccines can be broadly classified into two groups: 
1. Vaccines containing killed or inactivated pathogens, i.e. most bacteria vaccines and some virus vaccines (e.g. influenza virus inactivated by formalin, rabies virus inactivated by phenol and β-priolactone). 
2. Those containing live but attenuated pathogens, e.g., most virus vaccines. 
47
Attenuation means a drastic reduction in the virulence of a pathogen which is achieved as follows: 
Several consecutive passages through an animal, which is not the usual host of the pathogen, e.g., small pox virus in calf. 
Several passages through cultured cells of the host, e.g., rabies virus in human diploid cell culture, or of a different species, e.g., rabies virus, yellow fever virus in chick embryo cell culture. 
Selection of less virulent strains of pathogens, e.g., a mutant strain of polio virus. 
48
Treatment of the pathogen with some chemicals, e.g., B.C.G. (Bacillusof CalmetteGuerien) vaccine produced by culturing the bacteria on a medium containing bile. 
Culturing pathogens under unfavourableconditions like high temp, e.g., anthrax vaccine obtained by cultivation of the bacterium (Bacillus anthracis) at 40- 50 0C. 
In general, inactivation of virus is always coupled with attenuation to minimize the accidental presence of active virulent particles which could cause disease in the vaccinated individuals. 
49
Thedifferentvaccinesdifferintheircomposition, efficacyandthedurationofeffectiveprotectiontothevaccinatedindividuals.Theseareoneoftheearliestexamplesofbiotechnologicalinterventioninhumanandanimalhealthcare. 
50
Types of various vaccines 
There are various types of vaccines, 
1.Whole-Organism Vaccines (Conventional vaccines) 
2. Purified Macromolecules as Vaccines (Conventional ) 
3.Subunit Vaccine 
4.Recombinant-Vector Vaccines 
5.DNA Vaccines 
51
Whole organism vaccines 
Manyvaccinesnowavailableforhumans,andanimalusearemadeusingwholeorganisms(bacteriaorvirus),eitherintheinactivated(killed)formorattenuated(livebutavirulent)form. 
Examples:Salmonellatyphi(killedbacteria)againstTyphoid,Salmonellaparatyphi(killedbacteria)againstparatyphoid,Vibriocholerae(killedcellsorcellextract)againstcholera,Attenuatedvirusagainstyellowfever,measles,mumps,rubellaandpolio. 
52
PreparationandstorageofTyphoid-ParatyphoidAandBVaccine[TAB- Vaccine] 
Typhoidfever(entericfever)isanacutegeneralizedinfectioncausedbySalmonellatyphi;whereas,paratyphoidfeveriscausedbySalmonellaparatyphiAandSalmonellaparatyphiB. 
Preparation 
(1)Thevaccineispreparedbythegeneralprocessandcontainsthefollowingineachmillilitre:Typhoidbacilli(Salmonellatyphi):1000millionParatyphiAbacilli(S.paratyphiA)andParatyphiBbacilli(S.paratyphiB):500or750million. 
(2)ThesmoothstrainsofthethreeorganismsknowntoproducethefullcomplementofOsomaticantigensshouldbeused.ThisspecificstrainofS. typhimustcontainthevirusassociatedantigens(Vi-antigen). 
(3)Ithasbeendulyestablishedthatwhentheorganismswerekilledwith75% ethanolandtheresultingvaccinepreservedwith22.5%ethanol,thepotencyofthealcoholtreatedvaccinewasfoundtobealmostdoubletothatoftheheat-treatedvaccine,therebyminimizingthepossibilityofbothlocalandconstitutionalreactionwiththerelativelysmallerdose.Besides,alcoholtreatedvaccinesdidpossessdefinitelyandpredominantlylongerlifeundertheoptimalstorageconditions[viz.,storagebetween2-4°Cwithoutallowingthevaccinetofreeze]. 
53
Purified macromolecules as vaccine 
The purified antigenic portions from the bacterial cell wall, or viral coat protein are used as vaccines, and they can elicit immune reaction. Examples of macromolecule vaccines are: 
1.Capsular polysaccharides 
2.Surface antigens 
3.And inactivated exotoxinscalled toxoids. 
The macromolecule vaccines are generally safe since they don’t contain live organism. Example is given in next slide. 
54
Preparation of Meningococcal Polysaccharide Vaccine 
TheMeningococcalPolysaccharideVaccineconsistsofoneormorepurifiedpolysaccharidesobtainedfromappropriatestrainsofNeisseriameingitidisgroupA, groupC,groupYandgroupW135thathavebeenadequatelyprovedtobecapableofproducingpolysaccharidesthatareabsolutelysafeandalsocapableofinducingtheproductionofsatisfactorylevelsofspecificantibodyinhumans. 
Thevaccineispreparedimmediatelybeforeusebyreconstitutionfromthestabilizeddriedvaccinewithanappropriateprescribedsterileliquid.Itmayeithercontainasingletypeofpolysaccharideoranymixtureofthetypes. 
55
The various Preparation steps adopted are as stated under : 
(1)Thepreparationofthevacccineisbasedonaseed-lotsystem.Eachseed-lotissubjectedtomicrobiologicalexaminationbycultureinanappropriatemediaandmicroscopicexaminationofGram-stainedsmears. 
(2)Thepolysaccharideshowntobefreefromcontaminatingbacteriaisprecipitatedbytheadditionofcetrimoniumbromideandthenpurified. 
(3)Eachpolysaccharideisdissolvedunderasepticconditionsinasterilesolutioncontaininglactoseoranothersuitablestabilizingmediumforfreezedrying. 
(4)Thesolutionisblended,ifappropriate,withsolutionofthepolysaccharidesofanyoralloftheothergroupsandpassedthroughabacteria-retentivefilter. 
(5)Finally,thefiltrateisfreezedriedtoamoisturecontentshowntobefavourabletothestabilityofthevaccine 
56
Limitation of Conventional Vaccines 
Notallinfectiousagentscanbegrownincultureandnovaccineshavebeendevelopedforanumberofdiseases,wheretheinfectiousagentisnonculturable. 
Productionofanimalandhumanvirusesrequiresanimalcellculture,whichisexpensive. 
Yieldandrateofproductionofanimalvirusesislow. 
Extensivelaboratoryprecautionsareneededwhiledealingwithhighlyinfectiousagents. 
Inspiteofthebestprecautions,somebatchesofvaccinesmaynotbecompletelykilledorattenuated. 
Attenuatedstrainsmayreverttopathogenicstate,occasionally, andmaycauseactualdiseaseagainstwhichprotectionwassought. 
Notallinfectiousdiseasearepreventablebytraditionalvaccines(e.g.AIDS). 
HavelimitedShelf-lifethusrequiresrefrigeration. 
57
Vaccines made through recombinant DNA technology 
RecombinantDNAtechnologycanbebestusedinthefollowingwaysinvaccinedevelopment. 
1.Virulencegenescanbedeletedfromtheinfectiousagentretainingtheimmunogenicproperties. 
2.Anorganism(non-pathogenic)carryingantigenicdeterminantscanbecreatedbyinsertionofthegenescodingfortheantigenicproteins. 
3.Fornon-culturableagents,genesfortheprotein(criticalantigenicdeterminants)canbeclonedandexpressedinanexpressionvector(e.g.E.Colioramammaliancellline). 
4.Atargetedcell-specifickillingsystemthatkillsonlytheinfectedcellscanbedesigned.Inthistechnique,genefora‘fusionprotein’isconstructed.First,onepartofthefusionproteinbindstotheinfectedcell.Thentheotherpartkillstheinfectedcell. 
58
Subunit Vaccines 
Forviruses,ithasbeenshownthatspecificproteinfromthecoatorenvelopeisenoughtoelicittheimmuneresponse. 
Vaccineswithcomponentsofapathogenicorganismratherthanthewholeorganismarecalledsubunitvaccines.rDNAtechnologyisbestsuitedtodevelopsubunitvaccines. 
Purifiedproteinsaremorestableandarechemicallypreciseandsafefromsideeffects.However,purificationofproteincanbeexpensiveandsometimespurificationcanaltertheconfigurationofproteinandalteritsantigenicity!!! 
Thesefactorshavetobeassessedbeforemakingaproteinpreparation. 
OneoftheexampleofsubunitvaccinesdevelopedthroughrDNAtechwillbediscussedintheupcomingslides. 
59
Subunit vaccine for foot and mouth disease virus (FMDV) 
Formalin-killedFMDVwasusedasvaccineearlier.ThegenomeofFMDVissinglestrandedRNA(ssRNA). 
ThecDNAcomplementarytothisssRNA,8000nucleotidelongisprepared.Itisdigestedwithrestrictionenzymes,andthefragmentsareclonedinE.coli. 
Referfigure.Whiteboard!!!!!!!!!!!!!!!! 
60
Recombinant vector vaccines 
Genesthatencodemajorantigensofespeciallyvirulentpathogenscanbeintroducedintoattenuatedvirusesorbacteria. 
Theattenuatedorganismservesasavector,replicatingwithinthehostandexpressingthegeneproductofthepathogen. 
Anumberoforganismshavebeenusedforvectorvaccines, includingvacciniavirus(itismoststrongcandidateasitisefficientindeliveryandexpressionofclonedgenes), thecanarypoxvirus,attenuatedpoliovirus,adenovirus, attenuatedstrainsofSalmonella,theBCGstrainofMycobacteriumbovisandcertainstrainsofstreptococcusthatnormallyexistintheoralcavity. 
61
Vacciniavirushasbeenwidelyemployedasavectorvaccine.Thislarge,complexvirus,withagenomeofabout200genes,canbeengineeredtocarryseveraldozenforeigngeneswithoutimpairingitscapacitytoinfecthostcellsandreplicate. 
Theprocessofproducingavacciniavectorthatcarriesaforeigngenefromapathogenisoutlinedinfigurebelow. 
Thegeneticallyengineeredvacciniaexpresseshighleveloftheinsertedgeneproduct,whichcanthenserveasapotentimmunogeninaninoculatedhost. 
62
63
Likethesmallpoxvaccine,geneticallyengineeredvacciniavectorvaccinescanbeadministeredsimplybyscratchingtheskin,causinglocalizedinfectioninthehostcells. 
AntigengenesintroducedintoanimalcellsthroughvacciniavirusgenomeincluesRabiesvirusGprotein, HepatitisBsurfaceantigen,InfluenzavirusNPandHAproteins,etc. 
Iftheforeigngeneproductexpressedbythevacciniaisaviralenvelopeprotein,itisinsertedintothemembraneoftheinfectedhostcell,inducingdevelopmentofcell- mediatedimmunityaswellasantibodymediatedimmunity. 
Similartovacciniavectorvaccinesothervectorvaccineswhichhavebeenrecentlytriedincludecanarypoxvirus. 
64
DNA vaccines/ Gene vaccine (Genetic Immunization) 
PlasmidDNAencodingantigenicproteinsisinjecteddirectlyintothemuscleoftherecipient.MusclecellstakeuptheDNAandtheencodedproteinantigenisexpressed, leadingtobothahumoralandcell-mediatedresponse. 
TheDNAeitherintegrateintothechromosomalDNAortobemaintainedforlongperiodsinanepisomalform. 
Itoffersadvantageovermanyoftheexistingvaccinesfewofwhicharelistedbelow: 
1.Theencodedproteinisexpressedinthehostinitsnaturalform-thereisnodenaturationormodification.Duetothistheimmuneresponseisthereforedirectedtotheantigenexactlyasitisexpressedbythepathogen. 
65
2. It induces both humoral and cell mediated immunity. 
3. DNA vaccines cause prolonged expression of the antigen, which generates significant immunological memory. 
4. Refrigeration is not required for handling and storage of the plasmid DNA (thus lowers cost and complexity of delivery). 
5. The same plasmid vector could be custom tailored to make variety of proteins, so the same manufacturing techniques can be used for different DNA vaccines, each encoding an antigen from a different pathogen. 
66
AnimprovedmethodofadministeringthesevaccinesinvolvescoatingmicroscopicgoldbeadswiththeplasmidDNAandthendeliveringthecoatedparticlesthroughtheskinintotheunderlyingmusclewithanairgun(calledgenegun).Thiswillallowrapiddeliveryofavaccinetolargepopulationswithouttherequirementforhugesuppliesofneedlesandsyringes. 
TestofDNAvaccinesinanimalmodelshaveshownthesevaccinestobeeffectiveagainstvariousviraldiseasesincludinginfluenzavirus. 
67
Antigen-Antibody Interaction 
Theantigen-antibodyinteractionisabiomolecularassociationsimilartoanenzyme-substrateinteraction. 
However,itdoesn’tleadtoanirreversiblechemicalalterationineithertheantibodyortheantigen. 
Theassociationbetweenanantigenandantibodyinvolvesvariousnoncovalentinteractionsbetweentheantigenicdeterminant(epitope)oftheantigenandthevariable-region(VH/VL)domainoftheantibodymolecule,particularlythehypervariableregions,orcomplementarity-determiningregions(CDRs). 
68
69
Thenoncovalentinteractionsthatformthebasisofantigen-antibodybindingincludehydrogenbonds, ionicbonds,hydrophobicinteractions,andvanderWaalsinteractions. 
Sincetheseinteractionsareindividuallyweak(comparedwithacovalentbond),alargenumberofsuchinteractionsarerequiredtoformastrongAg-Abinteraction. 
Furthermore,eachofthesenoncovalentinteractionsoperatesoveraveryshortdistance(1angstromor1x10-7mm).HenceastrongAg-Abinteractiondependsonaveryclosefitbetweentheantigenandantibody. Suchfitrequireahighdegreeofcomplementaritybetweenantigenandantibody. 
70
Cross-reactivity 
AlthoughAg-Abreactionsarehighlyspecific,insomecasesantibodyelicitedbyoneantigencancross-reactwithanunrelatedantigen.Suchcross-reactivityoccursiftwodifferentantigensshareanidenticalorverysimilarepitope. 
Cross-reactivityisoftenobservedamongpolysaccharideantigensthatcontainssimilaroligosaccharideresidues. TheABOblood-groupantigens,forexample,areglycoproteinsexpressedonRBCs.SubtledifferencesintheterminalresiduesofthesugarsattachedtothesesurfaceproteinsdistinguishtheAandBbloodgroupantigens. 
RBCglycoproteinsugarsattachedtotheterminalendofitsubtledifferenceintheterminalresiduesofthesesugarsdistinguishAandBbloodgroupantigens. 
71
Anindividuallackingoneorbothoftheseantigenswillhaveserumantibodiestothemissingantigen(s). 
Theantibodiesareinducednotbyexposuretoredbloodcellantigensbutbyexposuretocross-reactingmicrobialantigenspresentoncommonintestinalbacteria. 
Thesemicrobialantigensinduceformationofantibodiesinindividualslackingthesimilarblood-groupantigensontheirRBCs. 
Theblood-groupantibodies,althoughelicitedbymicrobialantigens,willcross-reactwithsimilaroligosaccharidesonforeignRBCs.Thisprovidesthebasisforbloodtypingtestsandaccountsforthenecessityofcompatiblebloodtypesduringbloodtransfusions.TypeAindividualhasanti-Bantibodies,typeBhasanti-AandtypeOhasanti-A&B. 
72
Numerousvirusesandbacteriahaveepitopesidenticalorsimilartonormalhost-cellcomponents.Insomecases,thesemicrobialantigenshaveshowntoelicitantibodythatcross-reactswiththehost-cellcomponents,resultinginatissue-damagingautoimmunereaction. 
Fore.g.bacteriumStreptococcuspyrogenes,expresscellwallproteinscalledMantigens.Absproducedagainsttheseantigenshaveshowntocrossreactwithseveralmyocardialandskeletalmuscleproteinscausingkidneyandheartdamagefollowingstreptococcalinfections. 
Somevaccinesalsoexhibitcross-reactivity. 
73
74
1. Precipitation Reactions 
Antibodyandsolubleantigeninteractinginaqueoussolutionformalatticethateventuallydevelopsintoavariableprecipitate. 
Antibodiesthataggregatesolubleantigensarecalledprecipitins. 
AlthoughformationofthesolubleAg-Abcomplexoccurswithinminutes,formationofthevisibleprecipitateoccursmoreslowlyandoftentakesadayortwotoreachcompletion. 
FormationofAg-Ablatticedependsuponthevalencyofboth: 
1.Abshouldbebivalent;aprecipitatewillnotformwithmonovalentFabfragments. 
2.Agmustbeeitherbivalentorpolyvalenti.e.itmusthaveatleasttwocopiesofthesameepitopeorhavedifferentepitopesthatreactwithdifferentantibodiespresentinpolyclonalantisera. 
75
A. Precipitation reaction in fluids 
Precipitation reaction in fluids yields a precipitin Curve. 
A quantitative precipitation reaction can be performed by placing a constant amount of antibody in a series of tubes and adding increasing amount of antigen to the tubes. At one time this method was used to measure the amount of antigen or antibody present in a sample of interest. 
Once precipitate is formedeach tube centrifuged to pellet the precipitatesupernatant poured off amount of precipitate is measured. 
76
Plottingtheamountofprecipitateagainstincreasingantigenconcentrationsyieldsaprecipitincurve. 
Thefigurebelowshowsthattheexcessofeitherantigenorantibodiesinterfereswithmaximalprecipitation,whichoccursatequivalencepoint. 
Maximalprecipitationoccursatequivalencepoint. 
Asalargemacromolecularlatticeisformedatequivalence, complexincreasesinsizeandprecipitateout. 
Followfigureanddrawit!!!!itisimportanttodrawfigure. 
77
78
B. Precipitation Reaction in Gels 
PrecipitationrxningelsyieldsvisibleprecipitinLines. 
Immuneprecipitatescanformnotonlyinsolutionbutalsoinagarmatrix. 
Whenantigenandantibodydiffusestowardsoneanotherinagar,orwhenAbisincorporatedintotheagarandantigendiffusesintotheantibodycontainingmatrix,avisiblelineofprecipitationwillform. 
Asinprecipitationreactioninfluid,visibleprecipitationoccursintheregionofantibodyorantigenexcess. 
Twotypesofimmunodiffusionreactionscanbeusedtodeterminerelativeconcentrationofantibodiesorantigen, tocompareantigens,ortodeterminetherelativepurityofanantigenpreparation. 
79
Twotypesofimmunodiffusionreactionsbothofwhicharecarriedoutsemisolidmediumsuchasagar. 
1Radialimmunodiffusion(Mancinimethod):Inthismethod,anAgsampleisplacedinawellandallowedtodiffuseintoagarcontainingasuitabledilutionofantiserum.Asantigendiffusesintotheagar,theregionofequivalenceisestablishedandaringofprecipitation,aprecipitinring,formsaroundthewell. Theareaofprecipitinringisproportionaltotheconcentrationofantigen.Bycomparingtheareaoftheprecipitinringwithastandardcurve(obtainedbymeasuringtheprecipitinareasofknownconcentrationsoftheantigen),theconcentrationoftheantigensamplecanbedetermined. 
80
2. Double immunodiffusion (the Ouchterlony method): 
In this method both the antigen and antibody diffuse, radially from the wells towards each other , thereby establishing a concentration gradient. As equivalence is reached, a visible line of precipitation, a precipitin line is formed. 
Please refer figure in next slide!!!!!!!!!!!!!! 
81
82
2. Agglutination Reaction 
The interaction between antibody and antigen results in visible clumping called agglutination. 
Antibodies that produce such reactions are called agglutinins. 
Agglutination reaction are similar in principle to precipitation reactions; they depend on the crosslinking of polyvalent antigens. 
Just as an excess of antibody inhibits precipitation reactions, such excess can also inhibit agglutination reactions; this inhibition is called prozone effect. 
83
Its application 
a.Hemagglutinationisusedinbloodtyping: 
AgglutinationreactionsareroutinelyperformedtotypeRBCs. 
IntypingfortheABOantigens,RBCsaremixedonaslidewithantiseratotheAorBblood-groupantigens. 
Iftheantigenispresentonthecells,theyagglutinate, formingavisibleclumpontheslide. 
DeterminationofwhichantigensarepresentondonorandrecipientRBCsisthebasisformatchingbloodtypesfortransfusions. 
b.Bacterialagglutinationisusedtodiagnoseinfection. 
c.Passiveagglutinationisusefulwithsolubleantigens. 
84
Immuno-assay Techniques 
Radioimmunoassay 
ELISA 
Western Blotting 
Immunofluorescence 
Immunoelectron Microscopy. 
85
Immunoassays 
Theexquisitespecificityofantigen-antibodyinteractionshasledtothedevelopmentofavarietyofimmunologicassays,whichcanbeusedtodetectthepresenceofeitherantibodyorantigen. 
Immunoassayshaveplayedvitalrolesindiagnosingdiseases,monitoringthelevelofthehumoralimmuneresponse,andidentifyingmoleculesofbiologicalormedicalinterest.Theseassaysdifferintheirspeedandsensitivity,somearestrictlyqualitative,otherarequantitative. 
86
Radioimmunoassay 
Oneofthemostsensitivetechniquesfordetectingantigenorantibodyisradioimmunoassay(RIA). 
Principle:TheprincipleofRIAinvolvescompetitivebindingofradiolabeledantigen(usuallylabeledwithgammaemittingisotopesuchas125Ibutbetaemittingisotopessuchastritium3Harealsoroutinelyusedaslabels)toahigh-affinityantibody.Thelabeledantigenismixedwithantibodyataconcentrationthatsaturatestheantigen-bindingsitesoftheantibody. 
Thentestsamplesofunlabeledantigenofunknownconcentrationareaddedinprogressivelylargeramounts.Theantibodydoesn’tdistinguishlabeledfromunlabeledantigen,sothetwokindsofantigencompeteforavailablebindingsitesontheantibody. 
87
Astheconcentrationofunlabeledantigenincreases,morelabeledantigenwillbedisplacedfromthebindingsites. 
Thedecreaseintheamountofradiolabeledantigenboundtospecificantibodyinthepresenceofthetestsampleismeasuredinordertodeterminetheamountofantigenpresentinthetestsample.[Note:Todeterminetheamountoflabeledantigenbound,theAg-Abcomplexisprecipitatedtoseparateitfromfreeantigen,andtheradioactivityintheprecipitateismeasured. Astandardcurvecanbegeneratedusingunlabeledantigensamplesofknownconcentration(inplaceoftestsample),andfromthisplottheamountofantigeninthetestmixturemaybepreciselydetermined.] 
AmicrotiterRIAhasbeenwidelyusedtoscreenforthepresenceofthehepatitisBvirus. 
88
89
Enzyme-Linked Immunosorbent Assay 
CommonlyknownasELISA(orEIA). 
ItsprincipleissimilartoRIAbutdependsonanenzymeratherthanaradioactivelabel. 
Anenzymeconjugatedwithanantibodyreactswithacolorlesssubstratetogenerateacoloredreactionproduct. Suchasubstrateiscalledachromogenicsubstrate. 
AnumberofenzymeshavebeenemployedforELISA, includingalkalinephosphatase,horseradishperoxidase, andβ-galactosidase.TheseassaysapproachthesensitivityofRIAsandhavetheadvantageofbeingsafeandlesscostly. 
90
Types:3types. 
IndirectELISA:usedindeterminationofserumAbsagainstHIV. 
SandwichELISA 
CompetitiveELISA 
InoneoftheversionofELISAusingchemiluminescence,aluxogenic(light-generating) substrateisusedinplaceofchromogenicsubstrate(usedinconventionalELISA).Itsadvantageisincreasedsensitivity. 
91
92
IndirectELISA 
AntibodycanbedetectedorquantitativelydeterminedwithanindirectELISA(Figure6-10a).Serumorsomeothersamplecontainingprimaryantibody(Ab1)isaddedtoanantigen-coatedmicrotiterwellandallowedtoreactwiththeantigenattachedtothewell. 
AfteranyfreeAb1iswashedaway,thepresenceofantibodyboundtotheantigenisdetectedbyaddinganenzyme- conjugatedsecondaryanti-isotypeantibody(Ab2),whichbindstotheprimaryantibody. 
AnyfreeAb2theniswashedaway,andasubstratefortheenzymeisadded.Theamountofcoloredreactionproductthatformsismeasuredbyspecializedspectrophotometricplatereaders,whichcanmeasuretheabsorbanceofallofthewellsofa96-wellplateinseconds. 
93
IndirectELISAisthemethodofchoicetodetectthepresenceofserumantibodiesagainsthumanimmunodeficiencyvirus(HIV),thecausativeagentofAIDS.Inthisassay,recombinantenvelopeandcoreproteinsofHIVareadsorbedassolid-phaseantigenstomicrotiterwells. 
IndividualsinfectedwithHIVwillproduceserumantibodiestoepitopesontheseviralproteins.Generally,serumantibodiestoHIVcanbedetectedbyindirectELISAwithin6weeksofinfection. 
94
SANDWICH ELISA 
AntigencanbedetectedormeasuredbyasandwichELISA(Figure6-10b).Inthistechnique,theantibody(ratherthantheantigen)isimmobilizedonamicrotiterwell. 
Asamplecontainingantigenisaddedandallowedtoreactwiththeimmobilizedantibody. 
Afterthewelliswashed,asecondenzyme-linkedantibodyspecificforadifferentepitopeontheantigenisaddedandallowedtoreactwiththeboundantigen.Afteranyfreesecondantibodyisremovedbywashing,substrateisadded, andthecoloredreactionproductismeasured. 
95
COMPETITIVEELISA 
AnothervariationformeasuringamountsofantigeniscompetitiveELISA(Figure6-10c).Inthistechnique,antibodyisfirstincubatedinsolutionwithasamplecontainingantigen. 
Theantigen-antibodymixtureisthenaddedtoanantigencoatedmicrotiterwell.Themoreantigenpresentinthesample,thelessfreeantibodywillbeavailabletobindtotheantigen-coatedwell. 
Additionofanenzyme-conjugatedsecondaryantibody(Ab2)specificfortheisotypeoftheprimaryantibodycanbeusedtodeterminetheamountofprimaryantibodyboundtothewellasinanindirectELISA. 
Inthecompetitiveassay,however,thehighertheconcentrationofantigenintheoriginalsample,thelowertheabsorbance. 
96
Western blotting 
IndentificationofaspecificproteininacomplexmixtureofproteinscanbeaccomplishedbyatechniqueknownasWesternblotting. 
Inwesternblotting,aproteinmixtureiselectrophoreticallyseparatedonanSDS- polyacrylamidegel(SDS-PAGE),aslabgelinfusedwithsodiumdodecylsulfate(SDS),adissociatingagent. 
Theproteinbandsaretransferredtoanylonmembranebyelectrophoresisandtheindividualproteinbandsareidentifiedbyfloodingthenitrocellulosemembranewithradiolabeledorenzymelinkedpolyclonalormonoclonalantibodyspecificfortheproteinofinterest. 
TheAg-Abcomplexesthatisformedontheband,containingtheproteinrecognizedbytheantibody,canbevisualizedinavarietyofways.Iftheproteinofinterestwasboundbyaradioactiveantibody,itspositionontheblotcanbedeterminedbyexposingthemembranetoasheetofx-rayfilm,aprocedurecalledautoradiography. 
However,themostgenerallyuseddetectionproceduresemployenzyme-linkedantibodiesagainsttheprotein.Afterbindingoftheenzymeantibodyconjugate, additionofachromogenicsubstratethatproducesahighlycoloredandinsolubleproductcausestheappearanceofacoloredbandatthesiteofthetargetantigen. 
Thesiteoftheproteinofinterestcanbedeterminedwithmuchhighersensitivityifachemiluminescentcompoundalongwithsuitableenhancingagentsisusedtoproducelightattheantigensite. 
97
Westernblottingcanalsoidentifyaspecificantibodyinamixture.Inthiscase,knownantigensofwell-definedmolecularweightareseparatedbySDS-PAGEandblottedontonitrocellulose. 
Theseparatedbandsofknownantigensarethenprobedwiththesamplesuspectedofcontainingantibodyspecificforoneormoreoftheseantigens. 
Reactionofanantibodywithabandisdetectedbyusingeitherradiolabeledorenzyme-linkedsecondaryantibodythatisspecificforthespeciesoftheantibodiesinthetestsample. 
ThemostwidelyusedapplicationofthisprocedureisinconfirmatorytestingforHIV,whereWesternblottingisusedtodeterminewhetherthepatienthasantibodiesthatreactwithoneormoreviralproteins. 
98
99
Immunoprecipitation 
Theimmunoprecipitationtechniquehastheadvantageofallowingtheisolationoftheantigenofinterestforfurtheranalysis. 
Italsoprovidesasensitiveassayforthepresenceofaparticularantigeninagivencellortissuetype. 
Anextractproducedbydisruptionofcellsortissuesismixedwithanantibodyagainsttheantigenofinterestinordertoformanantigen-antibodycomplexthatwillprecipitate. 
However,iftheantigenconcentrationislow(oftenthecaseincellandtissueextracts),theassemblyofantigen-antibodycomplexesintoprecipitatescantakehours,evendays,anditisdifficulttoisolatethesmallamountofimmunoprecipitatethatforms. 
Whenusedinconjugationwithbiosyntheticradioisotopelabelling,immunoprecipitationcanalsobeusedtodeterminewhetheraparticularantigenisactuallysynthesizedbyacellortissue. 
100
101
Immunofluorescence 
In1944,AlbertCoonsshowedthatantibodiescouldbelabeledwithmoleculesthathavethepropertytofluorescence. 
Ifantibodymoleculesaretaggedwithfluorescentdye, orfluorochrome,immunecomplexescontainingthesefluorescentlylabeledantibodiescanbedetectedbycoloredlightemissionwhenexcitedbylightofappropriatewavelength. 
Antibodymoleculesboundtoantigensincellsortissuesectionscansimilarlybevisualized. 
Theemittedlightcouldbeviewedwithfluorescencemicroscope,whichisequippedwithUVlightsource. 
102
In this technique (immunofluorescence), various fluorescent compounds in use include Fluorescein, Rhodamine, Phycoerythrin. 
Fluorescent-antibody staining of cell membrane molecules or tissue sections can be direct or indirect. 
In direct staining, the specific antibody (the primary Ab) is directly conjugated with fluorescein. 
In indirect staining, the primary Ab is unlabeled and is detected with an additional flurochrome-labeled reagent. 
103
Immunoelectronmicroscopy 
Specificityofantibodyhasmadethempowerfultoolsforvisualizingspecificintracellulartissuecomponentsbyimmunoelectronmicroscopy. 
Inthistechnique, 
Electron-denselabelconjugatedtoFcportionofaspecificantibodyfordirectstainingorconjugatedtoananti-immunoglobulinreagentforindirectstaining Electrondenselabel(commonlyusedareferritinandcolloidalgold)absorbselectronsitcanbevisualisedwithelectronmicroscopeassmallblackdots. 
104
Monoclonal Antibodies 
MonoclonalAntibodiesareusuallyproducedfromhybridomaclones. 
Eachhybridomacloneisderivedbythefusionofamyelomacellandanantibodyproducinglymphocyte, andthehybridomacloneproducingthedesiredantibodyisidentifiedandisolated. 
Hybridomacellsaremass-culturedfortheproductionofmonoclonalantibodieseither(1)invivointheperitonealcavityofmiceor(2)invitroinlargescaleculturevessels. 
105
Application 
When Mabs are used to detect the presence of a specific antigen or of antibodies specific to an antigen in a sample or samples, this constitutes a diagnosic application. 
Antibodies specific to a cell type, say, tumor cells, can be linked with a toxin polypeptide to yield a conjugate molecule called immunotoxin. This immunotoxin will bind to tumor cell and kills it. 
Immunopurification. 
106
ANTIGENS AND HAPTENS 
Thetwoterminologiesviz.,antigensandhaptensareintimatelyassociatedwithimmunology;and,henceonemayunderstandandhaveaclearconceptaboutthemasfaraspossible. 
Antigens 
Anantigeniseitheracellormoleculewhichwillbindwithpreexitingantibodybutwillnotdefinitelycauseinductionofantibodyproduction. 
Antigenmayalsobedefinedas—‘amacromolecularentitythatessentiallyelicitsanimmuneresponseviatheformationofspecificantibodiesinthebodyofthehost’. 
Inabroaderperspectivetheantigen(orimmunogen)isinvariablyregardedastheafferentbranchoftheprevailingimmunesystem,andisanycellormoleculewhichwouldprovokeanimmuneresponseverymuchinanimmunologicallyviableandcompetentindividual.Generally,immunogens(antigens)mustfulfillthefollowingtwocharacteristicfeatures,namely: 
(a)shouldbelargerthan2000inmolecularweight,e.g.,protein,glycoproteinandcarbohydrates,and 
(b)mustbeabsolutelyforeigntotheindividualintowhomtheyhavebeenintroducedappropriately. 
107
Example:Thebestexampleofan‘antigen’isonesownerythrocytes.Because,theywillnotinduceantibodyformationinoneselfbutwilldefinitelyreactwithanantibodyessentiallycontainedinanimproperlymatchedbloodtransfusion. 
Quiteoftenanantigenisaprotein,butitcouldalsobeapolysaccharideornucleicacidoranyothersubstance. 
Importantly,itmayalsobepossiblethataforeignsubstance(e.g.,protein)-notnecessarilybelongingtoapathogenicmicroorganism,mayactasanantigensothatonbeinginjectedintoahost,itmayinduceantibodyformation. 
Besides,theymayturnouttobeantigenicandtherebycausestimulationofantibodyproduction,incasetheyareintimatelyandlightlygetboundtocertainmacromolecules,forinstance:proteins,carbohydratesandnucleicacids. 
108
Haptens 
Inusualpractice,therelativelysmaller,lessrigidorratherlesscomplexmoleculesusuallyarenotimmunogeneticintheirpurestform,butmaybemadesobysimplylinkingthemstrategicallytoeitherlargerormorecomplexstructures.Consequently,thesmallermoleculesareinvariablytermedashaptens;whereas,thelargermoleculesorcellsareknownascarriers. 
Haptenmayalsobedefined—‘asasubstancethatnormallydoesnotactasanantigenorstimulateanimmuneresponsebutthatcanbecombinedwithanantigenand,atalatertime,initiateaspecificantibodyresponseonitsown’. 
Furthermore,smallmolecules(micromolecular),suchas:drugsubstances,thatmayserveas‘haptens’andcannormallybemadeantigenicbycouplingthemchemicallytoamacromolecularsubstancee.g.,protein,polysaccharide,carbohydrateetc.Thehaptenisobtainedfromanon-antigeniccompound(micromolecule)e.g., morphine,carteololetc.,whichisultimatelyconjugated, covalentlytoacarriermacromoleculetorenderitantigenic. 
109
Oneofthegoodexampleisofgastrin(hapten)whichisdulycoupledtoalbumin(i.e.,proteincarrier)bytreatmentwithcarbodiimides(CCD),whichcouplefunctionalcarboxyl, amino,alcohol,phosphateorthiolmoieties. 
Importantly,thehapten-conjugatethusobtainedisnormallysubjectedtoemulsificationinahighlyrefined‘mineraloil’preparationcontaining-killedMycobacterium(CompleteFreund’sAdjuvant),andsubsequentlyinjectedintradermallyeitherinhealthyrabbitsorguineapigsonseveraloccasionsatintervals. 
Evidently,theserumantibodyshouldhavenotonlyhighdegreeofspecificitybutalsoareasonablystrongaffinityfortheprevailingantigens. 
110
Hypersensitivity 
Immunesystemmobilizesvarietyofeffectormoleculesthatacttoremoveantigenbyvariousmechanisms. 
Generally,theseeffectormoleculesinducealocalizedinflammatoryresponsethateliminatesantigenwithoutextensivelydamagingthehost’stissue.Undercertaincircumstances,however,thisinflammatoryresponsecanhavedeleteriouseffects,resultinginsignificanttissuedamageorevendeath.Thisinappropriateimmuneresponseistermedhypersensitivityorallergy. 
Althoughthewordhypersensitivityimpliesanincreasedresponse,theresponseisnotalwaysheightenedbutmay,instead,beaninappropriateimmuneresponsetoanantigen.Hypersensitivereactionsmaydevelopinthecourseofeitherhumoralorcell-mediatedresponses. 
Hypersensitivitymaybedefinedas—‘anabnormalsensitivitytoastimulusofanykind’. 
111
There are four types of hypersensitivity reaction: 
1.Type I hypersensitivity (IgEMediated Hypersensitivity) 
2.Type II (IgGMediated Hypersensitivity) 
3.Type III (Immune complex mediated hypersensitivity) 
4.Type IV (Cell Mediated Hypersensitivity) 
112
1. IgE mediated Hypersensitivity 
AtypeIhypersensitivereactionisinducedbycertaintypesofantigens(suchasforeignserum,vaccine,penicillin,ryegrass,antvenom,beevenom,etc)referredtoasallergens, andhasallthecharacteristicsofanormalhumoralresponse. 
Thatis,anallergeninducesahumoralantibodyresponsebythesamemechanismsasforothersolubleantigens,resultinginthegenerationofantibody-secretingplasmacellsandmemorycells. 
WhatdistinguishesatypeIhypersensitiveresponsefromanormalhumoralresponseisthattheplasmacellssecreteIgE.ThisclassofantibodybindswithhighaffinitytoFcreceptorsonthesurfaceoftissuemastcellsandbloodbasophils. 
MastcellsandbasophilscoatedbyIgEaresaidtobesensitized.Alaterexposuretothesameallergencross-linksthemembrane-boundIgEonsensitizedmastcellsandbasophils,causingdegranulationofthesecells. 
Thepharmacologicallyactivemediatorsreleasedfromthegranulesactonthesurroundingtissues.Theprincipaleffects—vasodilationandsmooth-musclecontraction—maybeeithersystemicorlocalized,dependingontheextentofmediatorrelease. 
TheclinicalmanifestationsoftypeIreactionscanrangefromlife-threateningconditions, suchassystemicanaphylaxisandasthma,tohayfeverandeczema,whicharemerelyannoying 
113
GeneralmechanismunderlyingatypeIhypersensitivereaction.ExposuretoanallergenactivatesBcellstoformIgEsecretingplasmacells.ThesecretedIgEmoleculesbindtoIgEspecificFcreceptorsonmastcellsandbloodbasophils. (ManymoleculesofIgEwithvariousspecificitiescanbindtotheIgE-Fcreceptor.)SecondexposuretotheallergenleadstocrosslinkingoftheboundIgE,triggeringthereleaseofpharmacologicallyactivemediators,vasoactiveamines,frommastcellsandbasophils.Themediatorscausesmooth-musclecontraction,increasedvascularpermeability,andvasodilation. 114
2. Antibody Mediated cytotoxic Hypersensitivity 
TypeIIhypersensitivereactionsinvolveantibody-mediateddestructionofcells. Antibodycanactivatethecomplementsystem,creatingporesinthemembraneofaforeigncell,oritcanmediatecelldestructionbyantibodydependentcell- mediatedcytotoxicity(ADCC).Inthisprocess,cytotoxiccellswithFcreceptorsbindtotheFcregionofantibodiesontargetcellsandpromotekillingofthecells.Antibodyboundtoaforeigncellalsocanserveasanopsonin,enablingphagocyticcellswithFcorC3breceptorstobindandphagocytosetheantibody-coatedcell. 
Examples : The various examples are as stated below : 
(i) Transfusion reactions i.e., when blood groups are not matched properly, 
(ii) Haemolytic disease concerning the newly born babies via Rhesus incompatibility, 
(iii) Graft destruction or rejection i.e., antibody-mediated ‘graft’ destruction or rejection. 
(iv) Autoimmune reactions usually directed against the formed elements of the blood, and the kidney glomerular basement membrances, etc. 
115
Example1:TransfusionReactionsAreTypeIIReactions 
Alargenumberofproteinsandglycoproteinsonthemembraneofredbloodcellsareencodedbydifferentgenes,eachofwhichhasanumberofalternativealleles.Anindividualpossessingoneallelicformofablood-groupantigencanrecognizeotherallelicformsontransfusedbloodasforeignandmountanantibodyresponse.Insomecases,theantibodieshavealreadybeeninducedbynaturalexposuretosimilarantigenicdeterminantsonavarietyofmicroorganismspresentinthenormalfloraofthegut.ThisisthecasewiththeABOblood-groupantigens. 
AntibodiestotheA,B,andOantigens,calledisohemagglutinins,areusuallyoftheIgMclass.AnindividualwithbloodtypeA,forexample,recognizesB-likeepitopesonintestinalmicroorganismsandproducesisohemagglutininstotheB-likeepitopes. 
IfatypeAindividualistransfusedwithbloodcontainingtypeBcells,atransfusionreactionoccursinwhichtheanti-Biso-hemagglutininsbindtotheBbloodcellsandmediatetheirdestructionbymeansofcomplement-mediatedlysis.Antibodiestootherblood-groupantigensmayresultfromrepeatedbloodtransfusionsbecauseminorallelicdifferencesintheseantigenscanstimulateantibodyproduction.TheseantibodiesareusuallyoftheIgGclass. 
Theclinicalmanifestationsoftransfusionreactionsresultfrommassiveintravascularhemolysisofthetransfusedredbloodcellsbyantibodypluscomplement.Thesemanifestationsmaybeeitherimmediateordelayed. 
116
117
HemolyticDiseaseoftheNewbornIsCausedbyTypeIIReactions 
HemolyticdiseaseofthenewborndevelopswhenmaternalIgGantibodiesspecificforfetalblood-groupantigenscrosstheplacentaanddestroyfetalredbloodcells.Theconsequencesofsuchtransfercanbeminor,serious,orlethal. 
Severehemolyticdiseaseofthenewborn,callederythroblastosisfetalis,mostcommonlydevelopswhenanRh+fetusexpressesanRhantigenonitsbloodcellsthattheRh–motherdoesnotexpress. 
This most commonly happens when a woman with Rhnegative blood becomes pregnant by a man with Rhpositive blood and conceives a baby with Rhpositive blood. 
Red blood cells from the baby can leak across the placenta into the woman's bloodstream during pregnancy or delivery. This causes the mother's body to make antibodies against the Rhfactor. 
If the mother becomes pregnant again with an Rh-positive baby, it is possible for her antibodies to cross the placenta and attack the baby's red blood cells. 
After birth, an affected newborn may develop kernicterus. This happens when bile pigments are deposited in the cells of the brain and spinal cord and nerve cells are degenerated. 
Incompatibilities between ABO blood types can also cause this condition. These are less common than those of the Rhfactor and tend to be less severe. 
118
3.ImmuneComplex–Mediated(TypeIII)Hypersensitivity 
Thereactionofantibodywithantigengeneratesimmunecomplexes.Generallythiscomplexingofantigenwithantibodyfacilitatestheclearanceofantigenbyphagocyticcells. 
Insomecases,however,largeamountsofimmunecomplexescanleadtotissue-damagingtypeIIIhypersensitivereactions. 
Themagnitudeofthereactiondependsonthequantityofimmunecomplexesaswellastheirdistributionwithinthebody. Whenthecomplexesaredepositedintissueverynearthesiteofantigenentry,alocalizedreactiondevelops. 
Whenthecomplexesareformedintheblood,areactioncandevelopwhereverthecomplexesaredeposited. 
Inparticular,complexdepositionisfrequentlyobservedonblood-vesselwalls,inthesynovialmembraneofjoints,ontheglomerularbasementmembraneofthekidney,andonthechoroidplexusofthebrain.Thedepositionofthesecomplexesinitiatesareactionthatresultsintherecruitmentofneutrophilstothesite.Thetissuethereisinjuredasaconsequenceofgranularreleaseoflyticenzymesfromtheneutrophil. 
119
TypeIIIhypersensitivereactionsdevelopwhenimmunecomplexesactivatethecomplementsystem’sarrayofimmuneeffectormolecules.TheC3a,C4a,andC5acomplementsplitproductsareanaphylatoxinsthatcauselocalizedmast- celldegranulationandconsequentincreaseinlocalvascularpermeability.C3a, C5a,andC5b67arealsochemotacticfactorsforneutrophils,whichcanaccumulateinlargenumbersatthesiteofimmune-complexdeposition.Largerimmunecomplexesaredepositedonthebasementmembraneofbloodvesselwallsorkidneyglomeruli,whereassmallercomplexesmaypassthroughthebasementmembraneandbedepositedinthesubepithelium.Thetypeoflesionthatresultsdependsonthesiteofdepositionofthecomplexes. 
MuchofthetissuedamageintypeIIIreactionsstemsfromreleaseoflyticenzymesbyneutrophilsastheyattempttophagocytoseimmunecomplexes. TheC3bcomplementcomponentactsasanopsonin,coatingimmunecomplexes. 
AneutrophilbindstoaC3b-coatedimmunecomplexbymeansofthetypeIcomplementreceptor,whichisspecificforC3b.Becausethecomplexisdepositedonthebasement-membranesurface,phagocytosisisimpeded,sothatlyticenzymesarereleasedduringtheunsuccessfulattemptsoftheneutrophiltoingesttheadheringimmunecomplex.Furtheractivationofthemembrane-attackmechanismofthecomplementsystemcanalsocontributetothedestructionoftissue.Inaddition,theactivationofcomplementcaninduce 
aggregationofplatelets,andtheresultingreleaseofclottingfactorscanleadtoformationofmicrothrombi. 
120
121
TypeIVorDelayed-TypeHypersensitivity(DTH) 
WhensomesubpopulationsofactivatedTHcellsencountercertaintypesofantigens,theysecretecytokinesthatinducealocalizedinflammatoryreactioncalleddelayed-typehyper-sensitivity(DTH). 
Thereactionischaracterizedbylargeinfluxesofnonspecificinflammatorycells,inparticular,macrophages. 
Thistypeofreactionwasfirstdescribedin1890byRobertKoch,whoobservedthatindividualsinfectedwithMycobacteriumtuberculosisdevelopedalocalizedinflammatoryresponsewheninjectedintradermally withafiltratederivedfromamycobacterialculture. 
Hecalledthislocalizedskinreactiona“tuberculinreaction.” 
ThecharacteristicofatypeIVreactionarethedelayintimerequiredforthereactiontodevelopandtherecruitmentofmacrophagesasopposedtoneutrophils,asfoundinatypeIIIreaction. 
Inthistype,sensitizedTH1cellsreleasecytokinesthatactivatemacrophagesorTCcellswhichmediatedirectcellulardamage. 
Macrophagesarethemajorcomponentoftheinfiltratethatsurroundsthesiteofinflammation. 
122
123
124
125
126
127
Antibody Production (Immunogen Preparation) 
Theproductionofspecificantibodyprobesisarelativelystraightforwardprocessinvolvingimmunizationofanimalsandrelianceupontheirimmunesystemstoraiseresponsesthatresultinbiosynthesisofantibodiesagainsttheinjectedmolecule.Evenso,severalfactorsaffecttheprobabilityofinducinganimmunizedanimaltoproduceusefulamountsoftarget-specificantibodies.Antigensmustbepreparedanddeliveredinaformandmannerthatmaximizesproductionofaspecificimmuneresponsebytheanimal.Thisiscalledimmunogenpreparation. 
128
Antibodyproductionisconceptuallysimple.However,becauseitdependsuponsuchacomplexbiologicalsystem(immunityofalivingorganism),resultsarenotentirelypredictable.Individualanimals– eventhosethataregeneticallyidentical–willresponduniquelytothesameimmunizationscheme,generatingdifferentsuitesofspecificantibodiesagainstaninjectedantigen.Evenso,equippedwithabasicunderstandingofhowtheimmunesystemrespondstoinjectionofaforeignsubstanceandaknowledgeofavailabletoolsforpreparingasampleforinjection,researcherscangreatlyincreasetheprobabilityofobtainingausefulantibodyproduct. 
Forexample,smallcompounds(drugsorpeptides)arenotsufficientlycomplexbythemselvestoinduceanimmuneresponseorbeprocessedinamannerthatelicitsproductionofspecificantibodies.Forantibodyproductiontobesuccessfulwithsmallantigens,theymustbechemicallyconjugatedwithimmunogeniccarrierproteinssuchaskeyholelimpethemocyanin(KLH).Adjuvantscanbemixedandinjectedwithanimmunogentoincreasetheintensityoftheimmuneresponse. 
129

More Related Content

What's hot

Four Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo CorrelationFour Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo CorrelationBhaswat Chakraborty
 
Antimicrobial used as preservatives
Antimicrobial used as preservativesAntimicrobial used as preservatives
Antimicrobial used as preservativespravinkshatriya
 
Phytosomes : Preparation and Application
Phytosomes : Preparation and ApplicationPhytosomes : Preparation and Application
Phytosomes : Preparation and ApplicationHemant Khandoliya
 
Griseofulvin Production by fermentation
Griseofulvin Production  by fermentation Griseofulvin Production  by fermentation
Griseofulvin Production by fermentation Vasundhara Kakade Pisal
 
UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...
UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...
UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...Shyam Bass
 
Applications of bio-pharmaceutics in new drug delivery
Applications of bio-pharmaceutics in new drug  deliveryApplications of bio-pharmaceutics in new drug  delivery
Applications of bio-pharmaceutics in new drug deliveryAkshata shettar
 
Phytosome® a novel drug delivery system based herbal formulation
Phytosome®  a novel drug delivery system based herbal formulationPhytosome®  a novel drug delivery system based herbal formulation
Phytosome® a novel drug delivery system based herbal formulationNitin Patel
 
Immune stimulation
Immune stimulationImmune stimulation
Immune stimulationAmeena Kadar
 
Study of immunological products
Study of  immunological productsStudy of  immunological products
Study of immunological productsSandhyaPunetha1
 
Cosmetic science
Cosmetic scienceCosmetic science
Cosmetic sciencePriya Patil
 
Uses of microbes in industry
Uses of microbes in industryUses of microbes in industry
Uses of microbes in industryAdarsh Patil
 

What's hot (20)

Sterile Products
Sterile Products Sterile Products
Sterile Products
 
Herbal excipients
Herbal excipientsHerbal excipients
Herbal excipients
 
Four Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo CorrelationFour Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo Correlation
 
Antimicrobial used as preservatives
Antimicrobial used as preservativesAntimicrobial used as preservatives
Antimicrobial used as preservatives
 
Phytosomes : Preparation and Application
Phytosomes : Preparation and ApplicationPhytosomes : Preparation and Application
Phytosomes : Preparation and Application
 
IVIVC
IVIVCIVIVC
IVIVC
 
Vaccines
VaccinesVaccines
Vaccines
 
Biologics
BiologicsBiologics
Biologics
 
Griseofulvin Production by fermentation
Griseofulvin Production  by fermentation Griseofulvin Production  by fermentation
Griseofulvin Production by fermentation
 
UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...
UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...
UNIT 6 Fermentation technology, Fermenters, Study of Media, types of fermenta...
 
Applications of bio-pharmaceutics in new drug delivery
Applications of bio-pharmaceutics in new drug  deliveryApplications of bio-pharmaceutics in new drug  delivery
Applications of bio-pharmaceutics in new drug delivery
 
Aerosols
AerosolsAerosols
Aerosols
 
Phytosome® a novel drug delivery system based herbal formulation
Phytosome®  a novel drug delivery system based herbal formulationPhytosome®  a novel drug delivery system based herbal formulation
Phytosome® a novel drug delivery system based herbal formulation
 
Immune stimulation
Immune stimulationImmune stimulation
Immune stimulation
 
Parenteral formulations
Parenteral formulationsParenteral formulations
Parenteral formulations
 
Bacterial toxoids
Bacterial toxoidsBacterial toxoids
Bacterial toxoids
 
Herbal drug formulation and evaluation
Herbal drug formulation and evaluationHerbal drug formulation and evaluation
Herbal drug formulation and evaluation
 
Study of immunological products
Study of  immunological productsStudy of  immunological products
Study of immunological products
 
Cosmetic science
Cosmetic scienceCosmetic science
Cosmetic science
 
Uses of microbes in industry
Uses of microbes in industryUses of microbes in industry
Uses of microbes in industry
 

Viewers also liked

Preparation and quality control of immunological products
Preparation and quality control of immunological productsPreparation and quality control of immunological products
Preparation and quality control of immunological productsMayur D. Chauhan
 
Immunological products quality control
Immunological products quality controlImmunological products quality control
Immunological products quality controlPh/Shaimaa Ahmadeen
 
Introduction to immunology
Introduction to immunologyIntroduction to immunology
Introduction to immunologypromotemedical
 
Four major immunologic methods
Four major immunologic methodsFour major immunologic methods
Four major immunologic methodsSunil Boreddy Rx
 
Class vaccines and sera
Class vaccines and sera Class vaccines and sera
Class vaccines and sera Raghu Prasada
 
Vaccination ppt
Vaccination pptVaccination ppt
Vaccination pptali7070
 
All about Tablets (Pharma)
All about Tablets  (Pharma)All about Tablets  (Pharma)
All about Tablets (Pharma)Sathish Vemula
 
10. adjuvants
10. adjuvants10. adjuvants
10. adjuvantsAlam Zeb
 
Immunologic methods basic methods
Immunologic methods basic methodsImmunologic methods basic methods
Immunologic methods basic methodsMohammed AlMujaini
 
Vaccine and adjuvants
Vaccine and adjuvantsVaccine and adjuvants
Vaccine and adjuvantsjonesomens
 
Tablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla MullaTablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla MullaAsad Mulla
 

Viewers also liked (20)

Preparation and quality control of immunological products
Preparation and quality control of immunological productsPreparation and quality control of immunological products
Preparation and quality control of immunological products
 
Immunological products quality control
Immunological products quality controlImmunological products quality control
Immunological products quality control
 
Introduction to immunology
Introduction to immunologyIntroduction to immunology
Introduction to immunology
 
Vaccines
VaccinesVaccines
Vaccines
 
Classification of Immunity
Classification of ImmunityClassification of Immunity
Classification of Immunity
 
Basic Immunology
Basic ImmunologyBasic Immunology
Basic Immunology
 
Vaccines and sera
Vaccines and seraVaccines and sera
Vaccines and sera
 
Four major immunologic methods
Four major immunologic methodsFour major immunologic methods
Four major immunologic methods
 
Class vaccines and sera
Class vaccines and sera Class vaccines and sera
Class vaccines and sera
 
Basic immunology
Basic immunologyBasic immunology
Basic immunology
 
Vaccination ppt
Vaccination pptVaccination ppt
Vaccination ppt
 
Vaccine production techniques
Vaccine production techniquesVaccine production techniques
Vaccine production techniques
 
Vaccine
VaccineVaccine
Vaccine
 
All about Tablets (Pharma)
All about Tablets  (Pharma)All about Tablets  (Pharma)
All about Tablets (Pharma)
 
10. adjuvants
10. adjuvants10. adjuvants
10. adjuvants
 
Immunologic methods basic methods
Immunologic methods basic methodsImmunologic methods basic methods
Immunologic methods basic methods
 
Vaccine and adjuvants
Vaccine and adjuvantsVaccine and adjuvants
Vaccine and adjuvants
 
Capsules
CapsulesCapsules
Capsules
 
Genetic recombination
Genetic recombinationGenetic recombination
Genetic recombination
 
Tablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla MullaTablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla Mulla
 

Similar to Immunology & immunological preparation

Overview of the immune system
Overview of the immune systemOverview of the immune system
Overview of the immune systemAmi Desai
 
An Introduction to Immunology PPT (1).ppt
An Introduction to Immunology PPT (1).pptAn Introduction to Immunology PPT (1).ppt
An Introduction to Immunology PPT (1).pptIbrahimKargbo13
 
Introduction Immunology .pptx
Introduction Immunology .pptxIntroduction Immunology .pptx
Introduction Immunology .pptxShafqatJaffer786
 
Introduction to Immunology
Introduction to ImmunologyIntroduction to Immunology
Introduction to ImmunologyMilan Taradi
 
Overview of immune response
Overview of immune responseOverview of immune response
Overview of immune responseMd Murad Khan
 
Chapter 1 Basic Immunology ppts DZ 2010.ppt
Chapter 1  Basic Immunology ppts DZ 2010.pptChapter 1  Basic Immunology ppts DZ 2010.ppt
Chapter 1 Basic Immunology ppts DZ 2010.pptKhotchawanBangpanwim
 
Chapter 1 Basic Immunology ppts DZ 2010.ppt
Chapter 1  Basic Immunology ppts DZ 2010.pptChapter 1  Basic Immunology ppts DZ 2010.ppt
Chapter 1 Basic Immunology ppts DZ 2010.pptDRSUDEEPSOLANKI
 
Chapter 1 Basic Immunology ppts DZ 2010.ppt
Chapter 1  Basic Immunology ppts DZ 2010.pptChapter 1  Basic Immunology ppts DZ 2010.ppt
Chapter 1 Basic Immunology ppts DZ 2010.pptDhandapanikuppusamy
 
2.innate and adaptive immunity power point
2.innate and adaptive immunity power point2.innate and adaptive immunity power point
2.innate and adaptive immunity power pointmulenga22
 
chapter 1 overview of the immune system.pptx
chapter 1 overview of the immune system.pptxchapter 1 overview of the immune system.pptx
chapter 1 overview of the immune system.pptxNabdNabd
 
Basics of immunology
Basics of immunologyBasics of immunology
Basics of immunologyShadab Khan
 
Basic immunology ppts for MLT or MD students.ppt
Basic immunology ppts for MLT or MD students.pptBasic immunology ppts for MLT or MD students.ppt
Basic immunology ppts for MLT or MD students.pptlemitesfa2
 
BIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISM
BIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISMBIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISM
BIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISMNirmala Josephine
 
1. Immunology and its history.pptx
1.       Immunology and its history.pptx1.       Immunology and its history.pptx
1. Immunology and its history.pptxMicrobiologyMicro
 

Similar to Immunology & immunological preparation (20)

Overview of the immune system
Overview of the immune systemOverview of the immune system
Overview of the immune system
 
An Introduction to Immunology PPT (1).ppt
An Introduction to Immunology PPT (1).pptAn Introduction to Immunology PPT (1).ppt
An Introduction to Immunology PPT (1).ppt
 
Introduction Immunology .pptx
Introduction Immunology .pptxIntroduction Immunology .pptx
Introduction Immunology .pptx
 
Chapter 1 The Basic Immunology
Chapter 1  The Basic ImmunologyChapter 1  The Basic Immunology
Chapter 1 The Basic Immunology
 
Introduction to Immunology
Introduction to ImmunologyIntroduction to Immunology
Introduction to Immunology
 
Overview of immune response
Overview of immune responseOverview of immune response
Overview of immune response
 
Sce mmuno1 26
Sce mmuno1 26Sce mmuno1 26
Sce mmuno1 26
 
Chapter 1 Basic Immunology ppts DZ 2010.ppt
Chapter 1  Basic Immunology ppts DZ 2010.pptChapter 1  Basic Immunology ppts DZ 2010.ppt
Chapter 1 Basic Immunology ppts DZ 2010.ppt
 
Chapter 1 Basic Immunology ppts DZ 2010.ppt
Chapter 1  Basic Immunology ppts DZ 2010.pptChapter 1  Basic Immunology ppts DZ 2010.ppt
Chapter 1 Basic Immunology ppts DZ 2010.ppt
 
Chapter 1 Basic Immunology ppts DZ 2010.ppt
Chapter 1  Basic Immunology ppts DZ 2010.pptChapter 1  Basic Immunology ppts DZ 2010.ppt
Chapter 1 Basic Immunology ppts DZ 2010.ppt
 
2.innate and adaptive immunity power point
2.innate and adaptive immunity power point2.innate and adaptive immunity power point
2.innate and adaptive immunity power point
 
chapter 1 overview of the immune system.pptx
chapter 1 overview of the immune system.pptxchapter 1 overview of the immune system.pptx
chapter 1 overview of the immune system.pptx
 
Vaccine converted
Vaccine convertedVaccine converted
Vaccine converted
 
Basics of immunology
Basics of immunologyBasics of immunology
Basics of immunology
 
Basic immunology ppts for MLT or MD students.ppt
Basic immunology ppts for MLT or MD students.pptBasic immunology ppts for MLT or MD students.ppt
Basic immunology ppts for MLT or MD students.ppt
 
Immunology -Immunity.ppt
Immunology -Immunity.pptImmunology -Immunity.ppt
Immunology -Immunity.ppt
 
Types of immunity
Types of immunityTypes of immunity
Types of immunity
 
BIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISM
BIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISMBIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISM
BIOLOGY FORM 5 CHAPTER 1 - 1.5 BODY DEFENCE MECHANISM
 
Immunity
ImmunityImmunity
Immunity
 
1. Immunology and its history.pptx
1.       Immunology and its history.pptx1.       Immunology and its history.pptx
1. Immunology and its history.pptx
 

More from Bijaya Kumar Uprety (16)

Progress, prospect and challenges in glycerol purification process
Progress, prospect and challenges in glycerol purification processProgress, prospect and challenges in glycerol purification process
Progress, prospect and challenges in glycerol purification process
 
Biodiesel production from oleaginous microorganisms
Biodiesel production from oleaginous microorganismsBiodiesel production from oleaginous microorganisms
Biodiesel production from oleaginous microorganisms
 
Value added products from glycerol
Value added products from glycerol Value added products from glycerol
Value added products from glycerol
 
Biodiesel production process
Biodiesel production processBiodiesel production process
Biodiesel production process
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Enzyme immobilization
Enzyme immobilizationEnzyme immobilization
Enzyme immobilization
 
Microbial transformation
Microbial transformationMicrobial transformation
Microbial transformation
 
Uv vis spectroscopy
Uv vis spectroscopyUv vis spectroscopy
Uv vis spectroscopy
 
NMR
NMRNMR
NMR
 
Mass spectrometry
Mass spectrometryMass spectrometry
Mass spectrometry
 
IR spectroscopy
IR spectroscopyIR spectroscopy
IR spectroscopy
 
Fluorimetry
FluorimetryFluorimetry
Fluorimetry
 
Flame emission spectroscopy
Flame emission spectroscopyFlame emission spectroscopy
Flame emission spectroscopy
 
Emission spectroscopy
Emission spectroscopyEmission spectroscopy
Emission spectroscopy
 
Atomic absorption spectroscopy
Atomic absorption spectroscopyAtomic absorption spectroscopy
Atomic absorption spectroscopy
 
Biopesticide
Biopesticide Biopesticide
Biopesticide
 

Recently uploaded

Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfWadeK3
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzohaibmir069
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PPRINCE C P
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfSELF-EXPLANATORY
 

Recently uploaded (20)

Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistan
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C P
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 

Immunology & immunological preparation